NEW YORK, Feb. 24 (GenomeWeb News) - Accelrys yesterday said that in the three months ending Dec. 31, 2005, it entered into "a number of comprehensive, multi-year agreements with some of the world's largest pharmaceutical companies."

The agreements include licenses for Accelrys' computational software and informatics platform totaling $29 million over the term of the agreements, said Accelrys in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.